CIK: 0001410830
Total reported value
$46.3M
Reporting period: 2026-03-31 · Number of holdings: 1
Matrix Capital Management Company, LP disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $46.3M and a quarterly turnover rate of 54.8%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "M"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add AURA
0.0% $8.6M
Sold out MAZE
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AURA | Aura Biosciences INC | Stock-Other | 100.00% | +34.52% | — |
Performance for Q3 2026
-2.1%
Performance Last 4 Quarters
+34.3%
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 1 | $46.3M | 55 | |
| 2025-12-31 | 2 | $57.6M | 60 | |
| 2025-09-30 | 3 | $106.7M | 100 | |
| 2025-06-30 | 4 | $222.8M | 0 | |
| 2025-03-31 | 4 | $347.2M | 100 | |
| 2024-12-31 | 5 | $2.2B | 0 | |
| 2024-09-30 | 7 | $2.1B | 0 | |
| 2024-06-30 | 23 | $13.1B | 0 | |
| 2024-03-31 | 23 | $10.8B | 0 | |
| 2023-12-31 | 19 | $9.7B | 0 | |
| 2023-09-30 | 19 | $8.3B | 0 | |
| 2023-06-30 | 19 | $8.6B | 0 | |
| 2023-03-31 | 17 | $7.4B | 0 | |
| 2022-12-31 | 17 | $5.2B | 0 | |
| 2022-09-30 | 26 | $5.2B | 0 | |
| 2022-06-30 | 20 | $4.4B | 0 | |
| 2022-03-31 | 25 | $8.3B | 0 | |
| 2021-12-31 | 22 | $9.0B | 0 | |
| 2021-09-30 | 23 | $8.8B | 0 | |
| 2021-06-30 | 23 | $9.2B | 25 | |
| 2021-03-31 | 30 | $8.7B | 27 | |
| 2020-12-31 | 29 | $9.2B | 28 | |
| 2020-09-30 | 29 | $7.5B | 34 | |
| 2020-06-30 | 23 | $6.4B | 57 | |
| 2020-03-31 | 22 | $3.9B | 49 | |
| 2019-12-31 | 22 | $4.7B | 17 | |
| 2019-09-30 | 24 | $4.1B | 65 | |
| 2019-06-30 | 24 | $5.4B | 39 | |
| 2019-03-31 | 20 | $3.7B | 36 | |
| 2018-12-31 | 19 | $3.0B | 46 | |
| 2018-09-30 | 21 | $4.0B | 18 | |
| 2018-06-30 | 20 | $3.5B | 27 | |
| 2018-03-31 | 21 | $2.9B | 32 | |
| 2017-12-31 | 20 | $2.8B | 40 | |
| 2017-09-30 | 17 | $3.1B | 19 | |
| 2017-06-30 | 18 | $2.9B | 25 | |
| 2017-03-31 | 13 | $2.4B | 45 | |
| 2016-12-31 | 12 | $2.0B | 41 | |
| 2016-09-30 | 15 | $2.4B | 26 | |
| 2016-06-30 | 15 | $2.2B | 14 | |
| 2016-03-31 | 14 | $2.1B | 38 | |
| 2015-12-31 | 17 | $2.2B | 25 | |
| 2015-09-30 | 18 | $2.2B | 27 | |
| 2015-06-30 | 20 | $2.2B | 23 | |
| 2015-03-31 | 19 | $1.9B | 48 | |
| 2014-12-31 | 17 | $1.9B | 33 | |
| 2014-09-30 | 18 | $1.9B | 13 | |
| 2014-06-30 | 18 | $1.8B | 49 | |
| 2014-03-31 | 19 | $1.5B | 54 | |
| 2013-12-31 | 20 | $1.4B | 20 | |
| 2013-09-30 | 18 | $1.2B | 37 | |
| 2013-06-30 | 16 | $951.1M | — |
Matrix Capital Management Company, LP's most significant position changes for 2026-03-31: Sold out: Maze Therapeutics INC (MAZE).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AURA | Aura Biosciences INC | +34.5% | — | Unchanged |
| 2 | MAZE | Maze Therapeutics INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-13 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-14 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-13 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-14 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-13 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-13 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-15 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-17 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-16 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-15 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-14 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-16 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-16 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-15 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-17 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-14 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-14 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-15 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
| 2013-09-30 | 2013-11-14 | 13F-HR | View on EDGAR |
| 2013-06-30 | 2013-08-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001536054
Total reported value
$46.3M
3 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001537403
Total reported value
$46.4M
2 stks
2019-12-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001236421
Total reported value
$46.4M
8 stks
2022-09-30
Stale — no recent filing
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0001715579
Total reported value
$981.8M
4 stks
2026-03-31
1 of the top 5 holdings overlap, including Aura Biosciences INC
CIK 0001747821
Total reported value
$299.6M
26 stks
2023-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Aura Biosciences INC